본문으로 건너뛰기
← 뒤로

Ultrasound-Guided Percutaneous Nerve Stimulation in Post-Stroke Spasticity: A Case Report.

Neurology international 2025 Vol.17(3) 🔓 OA Botulinum Toxin and Related Neurolog
OpenAlex 토픽 · Botulinum Toxin and Related Neurological Disorders Pain Management and Treatment Peripheral Nerve Disorders

Sartori F, Puig-Diví A, Picañol J

관련 도메인

📝 환자 설명용 한 줄

[INTRODUCTION] Post-stroke spasticity (PSS) significantly impacts the quality of life for stroke survivors.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Francesco Sartori, Albert Puig-Diví, Javier Picañol (2025). Ultrasound-Guided Percutaneous Nerve Stimulation in Post-Stroke Spasticity: A Case Report.. Neurology international, 17(3). https://doi.org/10.3390/neurolint17030034
MLA Francesco Sartori, et al.. "Ultrasound-Guided Percutaneous Nerve Stimulation in Post-Stroke Spasticity: A Case Report.." Neurology international, vol. 17, no. 3, 2025.
PMID 40137455

Abstract

[INTRODUCTION] Post-stroke spasticity (PSS) significantly impacts the quality of life for stroke survivors. While various treatments exist, options for refractory cases are limited. Ultrasound-guided percutaneous peripheral nerve stimulation (pPNS), commonly used in pain management, has not been studied for its potential use in spasticity management. This case report aims to evaluate the sensorimotor effects of pPNS in a patient with severe PSS.

[CASE DESCRIPTION] A 38-year-old male with severe PSS and functional limitations post-ischemic stroke in the middle cerebral artery underwent a six-week pPNS protocol (12 sessions). Low-frequency (2 Hz) stimulation targeted the median, musculocutaneous, and anterior interosseous nerves, while medium-frequency (10 Hz) stimulation targeted the posterior interosseous and radial nerves. Spasticity was assessed using the Modified Ashworth Scale (MAS) and Tardieu Scale (TS). Somatosensory assessments included tactile thresholds, pressure pain thresholds, and conditioned pain modulation (CPM).

[OUTCOMES] Spasticity decreased significantly, with reductions of 60.4% and 67.0% in elbow and wrist MAS scores, respectively, and a 49.5% reduction in TS scores. However, spasticity levels returned to baseline between sessions. Somatosensory assessments revealed increased tactile thresholds, decreased pressure pain thresholds, and an 81.3% reduction in CPM. The intervention was well tolerated, with minor transient effects, and the patient preferred pPNS over botulinum toxin injections.

[CONCLUSIONS] pPNS may effectively reduce spasticity and modulate somatosensory thresholds in PSS. These preliminary findings highlight its potential as an alternative treatment for refractory PSS, warranting further research with larger sample sizes and control groups to assess its broader clinical applicability.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1
해부 musculocutaneous scispacy 1
해부 radial nerves scispacy 1
해부 elbow scispacy 1
약물 PSS → Post-stroke spasticity scispacy 1
약물 CPM → conditioned pain modulation scispacy 1
약물 [INTRODUCTION] Post-stroke scispacy 1
질환 Post-Stroke Spasticity scispacy 1
질환 stroke C0038454
Cerebrovascular accident
scispacy 1
질환 pain C0030193
Pain
scispacy 1
질환 spasticity C0026838
Muscle Spasticity
scispacy 1
질환 post-ischemic stroke scispacy 1
질환 somatosensory scispacy 1
기타 Post-Stroke scispacy 1
기타 peripheral nerve scispacy 1
기타 cerebral artery scispacy 1
기타 anterior interosseous nerves scispacy 1
기타 posterior interosseous scispacy 1

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문